Values Company at $3.75 Billion and Funds Development of Additional Clinical ApplicationsMINNEAPOLIS--(BUSINESS WIRE)--#HistoSonics--HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced ... L'articolo HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors è un contenuto originale di 01net.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.